Merriman Curhan Ford Maintains Buy Brightpoint Inc. (CELL); European Exposure Not as Bad
Tweet Send to a Friend
Merriman Curhan Ford maintained coverage on Brightpoint Inc. (Nasdaq: CELL) with a Buy rating.
Merriman analyst says, "Shares of CELL ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Merriman analyst says, "Shares of CELL ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
